Navigation Links
Childhood Influenza Immunization Coalition Applauds Expanded Influenza Vaccine Recommendation for Children
Date:2/27/2008

All children 6 months to 18 years of age recommended for annual vaccination

ATLANTA, Feb. 27 /PRNewswire/ -- The National Foundation for Infectious Diseases' Childhood Influenza Immunization Coalition (CIIC) is pleased to support today's vote by the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) to expand the influenza vaccine recommendation for children 6 months up to 18 years of age. This recommendation is to be implemented as soon as feasible and no later than the 2009/10 influenza season.

"Each season many children remain vulnerable to the consequences of not being vaccinated against influenza," said Richard H. Carmona, M.D., M.P.H., FACS, CIIC Chair, 17th Surgeon General of the United States (2002-2006), President of Canyon Ranch Institute and Distinguished Professor of Public Health, The University of Arizona Mel and Enid Zuckerman College of Public Health. "We hope this expanded vaccination recommendation will strongly encourage Americans to get an annual influenza vaccination as soon as vaccine becomes available in their communities. This will help in reducing the number of childhood hospitalizations and deaths from influenza each season."

Influenza is a serious and potentially deadly disease that spreads very easily. Anyone can get influenza, but rates of infection are highest among children. Currently, the recommendation calls for annual vaccination of children 6 months up to 5 years of age. Vaccination is especially beneficial to both children and adults with certain chronic medical conditions like asthma, diabetes, heart disease and compromised immune systems. Not only are children at risk for influenza when unvaccinated, but infected children often transmit influenza to other vulnerable populations, such as grandparents and other caregivers age 50 and over. An expanded vaccination recommendation means greater protection for children and for the community at large.

"The Coalition welcomes ACIP's recommendation as we continue to educate the health care community and the general public about the severity of influenza," said Carol J. Baker, M.D., FAAP, FIDSA, CIIC Moderator, NFID President and Professor of Pediatrics, Molecular Virology and Microbiology, Baylor College of Medicine. "Influenza is very serious, but it is vaccine- preventable. Annual vaccination of children of all ages is the best way to protect children and interrupt virus transmission to others."

A Coalition report available on http://www.PreventChildhoodInfluenza.org outlines key strategies for health care professionals to help ensure all recommended children are vaccinated: offering influenza vaccination at all medical visits and making use of the entire influenza season -- vaccinating as soon as vaccine is available and continuing to vaccinate in January, February and beyond.

About the Childhood Influenza Immunization Coalition

The National Foundation for Infectious Diseases' (NFID) Childhood Influenza Immunization Coalition (CIIC) was established to protect infants, children and adolescents from influenza by communicating with "one strong voice" the need to make influenza immunization a national health priority. CIIC members represent 25 of the nation's leading public health, medical, patient and parent groups committed to protecting children's health and encouraging wellness.

The Childhood Influenza Immunization Coalition initiatives are made possible through an unrestricted educational grant to NFID from sanofi pasteur.

For more information on CIIC or childhood influenza, please visit http://www.preventchildhoodinfluenza.org.

Contact: Jennifer Corrigan

732-382-8898

732-742-7148 (Cell phone)


'/>"/>
SOURCE The National Foundation for Infectious Diseases
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. More than $6 Million Raised During Two-Day Event to Support Research and Treatment for Childhood Cancer and Other Catastrophic Diseases
2. NIH Funds Vaccine Research for Needle-free and Self-Administered Protection Against Pandemic Influenza
3. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
4. Vical to Participate in Pandemic Influenza Panel at JPMorgan Healthcare Conference
5. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
6. Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated
7. Vical Presentation at Military Pandemic Influenza Workshop
8. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
9. Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications
10. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
11. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , January 20, 2017 ... cancer is one of leading causes of death worldwide. ... Although the number of cancer related deaths increased gradually ... Rising in incidence rate of various cancers continues to ... a research report by Global Market Insights, Inc. cancer ...
(Date:1/19/2017)... Research and Markets has announced the addition ... Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... is projected to reach $15,737 million by 2022 from $6,521 in ... Omic technologies segment accounted for more than half ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... announced the formation of its Medical/Clinical Advisory Board. ... industry veterans who enhance the range and depth ... development of its novel prenatal diagnostic tests.  These ... and strategic guidance for the company,s product development ...
(Date:1/19/2017)... Research and Markets ... has announced the addition of the "Implantable Biomaterials ... report to their offering. Report Highlights: ... detailed analysis on current and future market trends to identify the investment ... as the base numbers Key market trends across the ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... sensor technology, today announced the launch of two ... systems, the highly-accurate biometric sensor modules that incorporate ... technology, experience and expertise. The two new designs ... specifically for hearables, and Benchmark BW2.0, a 2-LED ...
(Date:12/20/2016)... Dec. 20, 2016 The rising popularity ... and leasing is stoking significant interest in keyless ... technology, Bluetooth low energy (BLE), biometrics and near-field ... next wave of wireless technologies in the automotive ... to advanced access systems opens the market to ...
Breaking Biology News(10 mins):